BHWM
CUE icon

Beaird Harris Wealth Management’s Cue Biopharma CUE Stock Holding History

Beaird Harris Wealth Management’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-27
Closed -$1.51K – 730
2024
Q1 		$1.51K Hold
27
– – ﹤0.01% 500
2023
Q4 		$2.1K Hold
27
– – ﹤0.01% 455
2023
Q3 		$1.83K Hold
27
– – ﹤0.01% 365
2023
Q2 		$2.91K Hold
27
– – ﹤0.01% 354
2023
Q1 		$2.85K Hold
27
– – ﹤0.01% 353
2022
Q4 		$2.27K Hold
27
– – ﹤0.01% 560
2022
Q3 		$2K Hold
27
– – ﹤0.01% 395
2022
Q2 		$2K Hold
27
– – ﹤0.01% 345
2022
Q1 		$4K Hold
27
– – ﹤0.01% 444
2021
Q4 		$9K Buy
+27
New +$10.4K ﹤0.01% 411

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GLA
Good Life Advisors Reading, Pennsylvania $1.6B AUM 15.83% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Beaird Harris Wealth Management's CUE Position: Q2 2024 in Review

Beaird Harris Wealth Management sold out of Cue Biopharma (CUE) in Q2 2024, closing a stake of 27 shares — an estimated $1.51K sold.

Beaird Harris Wealth Management first reported a position in CUE in Q4 2021 and held it in 10 quarters. The position peaked at $9K in Q4 2021. 75 funds tracked by Wall St. Rank hold CUE as of Q2 2024.

  • Beaird Harris Wealth Management reported no remaining Cue Biopharma position as of Q2 2024 after selling out during the quarter.
  • Beaird Harris Wealth Management sold 27 Cue Biopharma shares in Q2 2024, an estimated $1.51K.
  • Beaird Harris Wealth Management first reported a position in Cue Biopharma in Q4 2021 and held it in 10 quarters.
  • Beaird Harris Wealth Management's Cue Biopharma position peaked at $9K in Q4 2021.
  • 75 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2024.

Based on Beaird Harris Wealth Management's 13F filing for Q2 2024, filed 15 Aug 2024.